Abbott Laboratories Revenue 2010-2024 | ABT
Abbott Laboratories annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Abbott Laboratories revenue for the quarter ending September 30, 2024 was $10.635B, a 4.85% increase year-over-year.
- Abbott Laboratories revenue for the twelve months ending September 30, 2024 was $41.217B, a 3.15% increase year-over-year.
- Abbott Laboratories annual revenue for 2023 was $40.109B, a 8.12% decline from 2022.
- Abbott Laboratories annual revenue for 2022 was $43.653B, a 1.34% increase from 2021.
- Abbott Laboratories annual revenue for 2021 was $43.075B, a 24.47% increase from 2020.
| Abbott Laboratories Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $40,109 |
| 2022 | $43,653 |
| 2021 | $43,075 |
| 2020 | $34,608 |
| 2019 | $31,904 |
| 2018 | $30,578 |
| 2017 | $27,390 |
| 2016 | $20,853 |
| 2015 | $20,405 |
| 2014 | $20,247 |
| 2013 | $19,657 |
| 2012 | $19,050 |
| 2011 | $21,407 |
| 2010 | $35,167 |
| 2009 | $30,765 |
| Abbott Laboratories Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-09-30 | $10,635 |
| 2024-06-30 | $10,377 |
| 2024-03-31 | $9,964 |
| 2023-12-31 | $10,241 |
| 2023-09-30 | $10,143 |
| 2023-06-30 | $9,978 |
| 2023-03-31 | $9,747 |
| 2022-12-31 | $10,091 |
| 2022-09-30 | $10,410 |
| 2022-06-30 | $11,257 |
| 2022-03-31 | $11,895 |
| 2021-12-31 | $11,468 |
| 2021-09-30 | $10,928 |
| 2021-06-30 | $10,223 |
| 2021-03-31 | $10,456 |
| 2020-12-31 | $10,701 |
| 2020-09-30 | $8,853 |
| 2020-06-30 | $7,328 |
| 2020-03-31 | $7,726 |
| 2019-12-31 | $8,314 |
| 2019-09-30 | $8,076 |
| 2019-06-30 | $7,979 |
| 2019-03-31 | $7,535 |
| 2018-12-31 | $7,765 |
| 2018-09-30 | $7,656 |
| 2018-06-30 | $7,767 |
| 2018-03-31 | $7,390 |
| 2017-12-31 | $7,589 |
| 2017-09-30 | $6,829 |
| 2017-06-30 | $6,637 |
| 2017-03-31 | $6,335 |
| 2016-12-31 | $5,333 |
| 2016-09-30 | $5,302 |
| 2016-06-30 | $5,333 |
| 2016-03-31 | $4,885 |
| 2015-12-31 | $5,188 |
| 2015-09-30 | $5,150 |
| 2015-06-30 | $5,170 |
| 2015-03-31 | $4,897 |
| 2014-12-31 | $5,356 |
| 2014-09-30 | $5,079 |
| 2014-06-30 | $5,057 |
| 2014-03-31 | $4,755 |
| 2013-12-31 | $4,008 |
| 2013-09-30 | $4,825 |
| 2013-06-30 | $5,446 |
| 2013-03-31 | $5,378 |
| 2012-12-31 | $3,188 |
| 2012-09-30 | $5,265 |
| 2012-06-30 | $5,313 |
| 2012-03-31 | $5,284 |
| 2011-12-31 | $10,377 |
| 2011-09-30 | $9,817 |
| 2011-06-30 | $9,616 |
| 2011-03-31 | $9,041 |
| 2010-12-31 | $9,968 |
| 2010-09-30 | $8,675 |
| 2010-06-30 | $8,826 |
| 2010-03-31 | $7,698 |
| 2009-12-31 | $8,790 |
| 2009-09-30 | $7,761 |
| 2009-06-30 | $7,495 |
| 2009-03-31 | $6,718 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $204.596B | $40.109B |
| Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Stryker (SYK) | United States | $148.564B | 33.48 |
| Boston Scientific (BSX) | United States | $132.954B | 38.22 |
| EssilorLuxottica (ESLOY) | France | $110.570B | 0.00 |
| Medtronic (MDT) | Ireland | $109.882B | 16.32 |
| Haleon (HLN) | United Kingdom | $43.411B | 28.21 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.162B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $37.697B | 19.55 |
| ResMed (RMD) | United States | $36.697B | 30.16 |
| Terumo (TRUMY) | Japan | $29.993B | 42.36 |
| Koninklijke Philips (PHG) | Netherlands | $25.294B | 19.36 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.026B | 14.02 |
| Insulet (PODD) | United States | $18.688B | 74.42 |
| Baxter (BAX) | United States | $16.783B | 10.92 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.061B | 0.00 |
| BellRing Brands (BRBR) | United States | $10.147B | 40.82 |
| Bio-Rad Laboratories (BIO) | United States | $9.455B | 32.13 |
| Demant (WILYY) | Denmark | $8.342B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.225B | 14.46 |
| TG Therapeutics (TGTX) | United States | $5.333B | 0.00 |
| Haemonetics (HAE) | United States | $4.446B | 21.70 |
| Prestige Consumer Healthcare (PBH) | United States | $4.110B | 20.44 |
| Perrigo (PRGO) | Ireland | $3.866B | 11.38 |
| ICU Medical (ICUI) | United States | $3.862B | 36.77 |
| Envista Holdings (NVST) | United States | $3.786B | 28.20 |
| Agios Pharmaceuticals (AGIO) | United States | $3.370B | 0.00 |
| Neogen (NEOG) | United States | $3.071B | 35.42 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.867B | 18.39 |
| QuidelOrtho (QDEL) | United States | $2.756B | 17.74 |
| Warby Parker (WRBY) | United States | $2.455B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $2.370B | 57.61 |
| Green Thumb Industries (GTBIF) | United States | $1.977B | 34.59 |
| AtriCure (ATRC) | United States | $1.745B | 0.00 |
| InMode (INMD) | Israel | $1.617B | 9.72 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.419B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.339B | 9.57 |
| Curaleaf Holdings (CURLF) | Canada | $1.293B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.255B | 0.00 |
| Owens & Minor (OMI) | United States | $1.017B | 7.95 |
| CeriBell (CBLL) | United States | $0.992B | 0.00 |
| National Vision Holdings (EYE) | United States | $0.980B | 32.75 |
| Phibro Animal Health (PAHC) | United States | $0.961B | 16.95 |
| Capricor Therapeutics (CAPR) | United States | $0.867B | 0.00 |
| Evolus (EOLS) | United States | $0.812B | 0.00 |
| Omeros (OMER) | United States | $0.704B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.679B | 30.02 |
| Cresco Labs (CRLBF) | United States | $0.591B | 0.00 |
| Surmodics (SRDX) | United States | $0.567B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.522B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.473B | 0.00 |
| Quanterix (QTRX) | United States | $0.463B | 0.00 |
| ZimVie (ZIMV) | United States | $0.401B | 33.77 |
| Biote (BTMD) | United States | $0.364B | 7.96 |
| Viemed Healthcare (VMD) | United States | $0.337B | 32.07 |
| Cerus (CERS) | United States | $0.327B | 0.00 |
| Valneva SE (VALN) | France | $0.325B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.324B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.286B | 19.15 |
| Zynex (ZYXI) | United States | $0.265B | 55.53 |
| Aurora Cannabis (ACB) | Canada | $0.242B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.234B | 0.00 |
| High Tide (HITI) | Canada | $0.225B | 93.33 |
| Utah Medical Products (UTMD) | United States | $0.221B | 15.26 |
| MacroGenics (MGNX) | United States | $0.213B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.177B | 2.49 |
| Brainsway (BWAY) | Israel | $0.162B | 97.10 |
| Organigram Holdings (OGI) | Canada | $0.160B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.157B | 19.71 |
| Zevia PBC (ZVIA) | United States | $0.155B | 0.00 |
| Jin Medical (ZJYL) | China | $0.136B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.132B | 0.00 |
| Veru (VERU) | United States | $0.108B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.106B | 0.00 |
| Fonar (FONR) | United States | $0.104B | 11.75 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.079B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.073B | 37.50 |
| Exagen (XGN) | United States | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.069B | 0.00 |
| InterCure (INCR) | Israel | $0.066B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.064B | 0.00 |
| Modular Medical (MODD) | United States | $0.057B | 0.00 |
| MariMed (MRMD) | United States | $0.055B | 0.00 |
| Apyx Medical (APYX) | United States | $0.055B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.049B | 0.00 |
| Safety Shot (SHOT) | United States | $0.049B | 0.00 |
| ImmuCell (ICCC) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.025B | 0.00 |
| Flora Growth (FLGC) | United States | $0.021B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.017B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.63 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |